Statin utilisation vs. AMI-incidence | |||||
---|---|---|---|---|---|
Male | Female | ||||
Age | Year | r | β 1 | r | β 1 |
40-49 | 1998 | 0.051 | 0.005 | 0.061 | 0.009 |
1999 | 0.303*** | 0.046*** | 0.165** | 0.024* | |
2000 | 0.131* | 0.011 | 0.115 | 0.011 | |
2001 | 0.126* | 0.017* | 0.040 | -0.005 | |
2002 | 0.037 | 0.001 | -0.071 | -0.008 | |
50-59 | 1998 | 0.141* | 0.007 | 0.086 | 0.004 |
1999 | 0.287*** | 0.028*** | 0.017 | -0.017* | |
2000 | 0.141* | 0.011 | 0.064 | -0.002 | |
2001 | -0.047 | -0.016** | 0.115 | 0.004 | |
2002 | -0.000 | -0.006 | 0.148* | 0.003 | |
60-69 | 1998 | 0.052 | 0.010 | 0.097 | -0.0005 |
1999 | 0.026 | 0.003 | 0.146* | 0.002 | |
2000 | -0.032 | -0.001 | 0.146* | 0.010 | |
2001 | 0.081 | 0.009 | -0.017 | -0.006 | |
2002 | -0.042 | -0.004 | 0.051 | -0.004 | |
70-79 | 1998 | -0.168** | -0.042* | -0.137* | -0.031 |
1999 | -0.172** | -0.040* | -0.154** | -0.032* | |
2000 | -0.170** | -0.026* | -0.042 | -0.006 | |
2001 | -0.024 | 0.005 | -0.036 | -0.007 | |
2002 | -0.082 | -0.009 | -0.062 | -0.004 |